首页 | 本学科首页   官方微博 | 高级检索  
检索        


Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study
Authors:Cedric Lebacle  Karim Bensalah  Jean-Christophe Bernhard  Laurence Albiges  Brigitte Laguerre  Marine Gross-Goupil  Herve Baumert  Herve Lang  Thibault Tricard  Brigitte Duclos  Armelle Arnoux  Celine Piedvache  Jean-Jacques Patard  Bernard Escudier
Institution:1. Department of Urology, Bicetre University Hospital, Assistance Publique-Hôpitaux de Paris, APHP, University Paris-Saclay, Le Kremlin-Bicetre, France;2. Department of Urology, Pontchaillou University Hospital, Rennes, France;3. Department of Urology, Bordeaux University Hospital, Pellegrin Hospital, Bordeaux, France

French Research Network on Kidney Cancer UroCCR, Bordeaux, France;4. Department of Medicine, Gustave Roussy, University Paris-Saclay, Villejuif, France;5. Department of Oncology, Eugene Marquis Centre, Rennes, France;6. Department of Medical Oncology, Bordeaux University Hospital, Saint-Andre Hospital, Bordeaux, France;7. Department of Urology, Saint-Joseph Hospital, Paris, France;8. Department of Urology, Nouvel Hopital Civil, Strasbourg University Hospital, Strasbourg, France;9. Department of Oncology, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France;10. Paris-Sud Clinical Research Unit, Department of Statistics, Bicetre University Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France;11. Department of Urology, Mont de Marsan Hospital, Mont de Marsan, France

Abstract:
Keywords:neoadjuvant  partial nephrectomy  renal cell carcinoma  targeted therapy  #uroonc
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号